<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0038443" disease_type="Mental or Behavioral Dysfunction" abbrv="">Psychological stress</z:e>-associated <z:hpo ids='HP_0002958'>immune dysregulation</z:hpo> has been shown to disrupt the steady-state expression and reactivate latent <z:e sem="disease" ids="C0019340" disease_type="Disease or Syndrome" abbrv="">herpes</z:e> viruses </plain></SENT>
<SENT sid="1" pm="."><plain>One such virus is the Epstein Barr virus (EBV), which is associated with several human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>EBV infects &gt;90% of people living in North America and persists for life in latently infected cells </plain></SENT>
<SENT sid="3" pm="."><plain>Although several studies have shown that <z:chebi fb="1" ids="24261">glucocorticoids</z:chebi> (GCs) can directly induce reactivation of the latent virus, the mechanism of stress hormone involvement in the control of EBV gene expression is not well understood </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, we tested the hypothesis that GCs can induce the latent EBV genome to lytically replicate through the induction of the EBV immediate early gene BZLF1 which encodes the lytic transactivator protein ZEBRA </plain></SENT>
<SENT sid="5" pm="."><plain>We show a dose-dependent upregulation of BZLF1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression by <z:chebi fb="2" ids="17650">hydrocortisone</z:chebi> (HC) and <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> (Dex) in Daudi cells, an EBV genome positive Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line, and Dex-induction of the early gene products BLLF3 (encoding for the EBV dUTPase) and BALF5 (encoding for the EBV DNA polymerase) </plain></SENT>
<SENT sid="6" pm="."><plain>We show that Daudi cells express <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> receptors (GR) that mediate Dex-dependent upregulation of BZLF1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels </plain></SENT>
<SENT sid="7" pm="."><plain>This effect was inhibited by both the <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> RU486 and by <z:chebi fb="0" ids="27641">cycloheximide</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>The results suggest that GCs, in addition to inducing stress-related <z:hpo ids='HP_0002958'>immune dysregulation</z:hpo>, can mediate latent EBV reactivation through the induction of the BZLF1 gene </plain></SENT>
</text></document>